Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Ophthalmic Genet ; 44(1): 35-42, 2023 02.
Article in English | MEDLINE | ID: mdl-36377647

ABSTRACT

BACKGROUND: X-linked juvenile retinoschisis (×LRS) is an X-linked vitreoretinal degenerative disease that consists of variable phenotypes ranging from severe early-onset defects to subtle abnormalities diagnosed in elderly patients. XLRS is caused by a loss of function of the protein Retinoschisin (RS1), which is essential to preserve retinal integrity and function of photoreceptor-bipolar synapse. The literature data so far mostly agree on the absence of a clear genotype-phenotype correlation in XLRS. We reviewed clinical and molecular characteristics of a cohort of Italian pediatric XLRS patients to assess the presence of a correlation between genotype and phenotype severity. MATERIALS AND METHODS: We retrospectively examined clinical and genetic features of a cohort of 27 XLRS patients. In this study we included patients with a diagnosis of XLRS confirmed by fundus photography, spectral domain optical coherence tomography, and molecular analysis and with an onset of less than 10 years of age. We sorted RS1 variants according to their effect of RS1 structure and function in three separate groups. RESULTS: According to previous studies, we did not observe a conclusive genotype-phenotype correlation in our cohort; nevertheless, we noticed that patients harboring RS1 variants leading to RS1-secreted mutants show a more homogeneous phenotype, with an overall good visual acuity, compared to the other two groups. CONCLUSIONS: Our data support the hypothesis that secretion profile of RS1 could influence the severity of the phenotype. More extensive and functional studies are needed to acquire notions in view of the opportunity of gene replacement therapy for XLRS patients.


Subject(s)
Retinoschisis , Humans , Retinoschisis/diagnosis , Retinoschisis/genetics , Retrospective Studies , Electroretinography , Mutation , Phenotype , Genotype , Eye Proteins/metabolism , Tomography, Optical Coherence
2.
Int J Immunopathol Pharmacol ; 25(3): 775-80, 2012.
Article in English | MEDLINE | ID: mdl-23058030

ABSTRACT

Vernal keratoconjunctivitis (VKC) is a severe chronic bilateral inflammation of the ocular surface characterized by seasonal exacerbations. Long-term prognosis is generally good; however, 6% develop sequelae responsible for permanent visual impairment. Corneal involvement is almost always present, consisting of punctate keratitis, shield ulcers (3-11%) and late corneal neovascularization. In recent years, topical cyclosporine A preparations at 2% in oil or at 1% in polyvinyl alcohol, have been successfully proposed for long term VKC treatments. It has been previously proven that medical treatment is not always sufficient, especially when it is employed to treat shield ulcer plaques. In such conditions, surgery may be effective for avoiding long term complications such as amblyopia, strabismus, infections and corneal perforation. In this paper, we show the efficacy of surgical debridement by means of simple scraping associated with topical cyclosporine treatment for the management of vernal shield ulcers complicated with plaques.


Subject(s)
Conjunctivitis, Allergic/therapy , Corneal Ulcer/therapy , Cyclosporine/administration & dosage , Debridement , Immunosuppressive Agents/administration & dosage , Administration, Ophthalmic , Adolescent , Child , Combined Modality Therapy , Conjunctivitis, Allergic/diagnosis , Conjunctivitis, Allergic/drug therapy , Conjunctivitis, Allergic/surgery , Corneal Ulcer/diagnosis , Corneal Ulcer/drug therapy , Corneal Ulcer/surgery , Diagnostic Techniques, Ophthalmological , Female , Humans , Italy , Male , Ophthalmic Solutions , Severity of Illness Index , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL